Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment

Nucleos(t)ide analogues rarely result in a durable off-treatment response in chronic hepatitis B infection, whereas pegylated interferon (Peg-IFN) induces a long-lasting response only in a subset of patients. We assessed the effect of sequential combination therapy with Peg-IFN-α2a and entecavir in...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Antimicrob Agents Chemother
Main Authors: Li, Guo-Jun, Yu, Yi-Qi, Chen, Shao-Long, Fan, Ping, Shao, Ling-Yun, Chen, Jia-Zhen, Li, Chang-Shui, Yi, Bin, Chen, Wei-Cun, Xie, Shu-Yuan, Mao, Xiao-Na, Zou, He-Hui, Zhang, Wen-Hong
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2015
נושאים:
Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4468690/
https://ncbi.nlm.nih.gov/pubmed/25941216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00249-15
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים